Similar articles for PMID: 31767011

Year	Number of Results
2016	1
2017	3
2018	4
2019	19
2020	26
2021	21
2022	27
2023	17
2024	4

1

Opioid use disorder and treatment: challenges and opportunities.

Hoffman KA, Ponce Terashima J, McCarty D. Hoffman KA, et al. BMC Health Serv Res. 2019 Nov 25;19(1):884. doi: 10.1186/s12913-019-4751-4. BMC Health Serv Res. 2019. PMID: 31767011 Free PMC article. Review.

2

Prescription of Controlled Substances: Benefits and Risks.

Preuss CV, Kalava A, King KC. Preuss CV, et al. 2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Apr 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30726003 Free Books & Documents.

3

Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.

Hughto JMW, Tapper A, Rapisarda SS, Stopka TJ, Palacios WR, Case P, Silcox J, Moyo P, Green TC. Hughto JMW, et al. Subst Abuse Treat Prev Policy. 2023 May 22;18(1):30. doi: 10.1186/s13011-023-00538-x. Subst Abuse Treat Prev Policy. 2023. PMID: 37217975 Free PMC article.

4

Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.

Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Wakeman SE, et al. JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622. JAMA Netw Open. 2020. PMID: 32022884 Free article.

5

Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.

Bart GB, Saxon A, Fiellin DA, McNeely J, Muench JP, Shanahan CW, Huntley K, Gore-Langton RE. Bart GB, et al. Addict Sci Clin Pract. 2020 Jan 16;15(1):4. doi: 10.1186/s13722-020-0180-2. Addict Sci Clin Pract. 2020. PMID: 31948487 Free PMC article.

6

Alho H, Dematteis M, Lembo D, Maremmani I, Roncero C, Somaini L. Alho H, et al. Int J Drug Policy. 2020 Feb;76:102616. doi: 10.1016/j.drugpo.2019.102616. Epub 2019 Dec 16. Int J Drug Policy. 2020. PMID: 31855706 Free article.

7

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts.

Chatterjee A, Weitz M, Savinkina A, Macmadu A, Madushani RWMA, Potee RA, Ryan D, Murphy SM, Walley AY, Linas BP. Chatterjee A, et al. JAMA Netw Open. 2023 Apr 3;6(4):e237036. doi: 10.1001/jamanetworkopen.2023.7036. JAMA Netw Open. 2023. PMID: 37058306 Free PMC article.

8

Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.

Jones CM, Shoff C, Blanco C, Losby JL, Ling SM, Compton WM. Jones CM, et al. JAMA Psychiatry. 2023 May 1;80(5):508-514. doi: 10.1001/jamapsychiatry.2023.0310. JAMA Psychiatry. 2023. PMID: 36988913 Free PMC article.

9

Medications for management of opioid use disorder.

Koehl JL, Zimmerman DE, Bridgeman PJ. Koehl JL, et al. Am J Health Syst Pharm. 2019 Jul 18;76(15):1097-1103. doi: 10.1093/ajhp/zxz105. Am J Health Syst Pharm. 2019. PMID: 31361869 Review.

10

Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.

Jones CM, Shoff C, Hodges K, Blanco C, Losby JL, Ling SM, Compton WM. Jones CM, et al. JAMA Psychiatry. 2022 Oct 1;79(10):981-992. doi: 10.1001/jamapsychiatry.2022.2284. JAMA Psychiatry. 2022. PMID: 36044198 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year